lawsuit Archives - Journal for Clinical Studies

Regional News

Shkreli’s former company Vyera settles for $40M in antitrust case, but ‘pharma bro’ still faces his own trials

A fraud conviction and seven-year prison sentence haven’t spared “Pharma Bro” and Wu-Tang Clan enthusiast Martin Shkreli from a federal antitrust lawsuit tied to his ...

13 December 2021 Regional News antitrust | Daraprim

Continue Reading →

Regional News

As end of New York opioid trial nears, AbbVie’s Allergan ponies up $200M to settle its part of the case

On the day of closing arguments in a high-profile New York opioid trial, AbbVie has inked a $200 million settlement to put the case to bed. AbbVie's Allergan has agr...

13 December 2021 Regional News AbbVie | allergan

Continue Reading →

Regional News

Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut

Alvotech, the biosim specialist locked in a legal battle over AbbVie's sales Goliath Humira, is revving up for its debut on the Nasdaq. The Icelandic company is join...

8 December 2021 Regional News AbbVie | Alvotech

Continue Reading →

Regional News

Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron

After Amgen earlier this year suffered a third consecutive loss in its high-profile PCSK9 patent feud with Sanofi and Regeneron, the company faced two choices: appeal...

1 December 2021 Regional News Amgen | lawsuit

Continue Reading →

Derisking FIH Integrated Strategies

Current Edition

Shkreli’s former company Vyera settles for $40M in antitrust case, but ‘pharma bro’ still faces his own trials

As end of New York opioid trial nears, AbbVie’s Allergan ponies up $200M to settle its part of the case

Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut

Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron

Journal for Clinical Studies